{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:12:50Z","timestamp":1788970370427,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.anndiagpath.2026.152709","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:22:01Z","timestamp":1787552521000},"page":"152709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ERG and CD31 expression in acute megakaryoblastic leukemia and myeloid sarcoma: A diagnostic pitfall"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4678-2047","authenticated-orcid":false,"given":"Ali Y\u0131lmaz","family":"Altay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naciye Bet\u00fcl","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simge","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u00e7in","family":"Yegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2026.152709_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30251","article-title":"Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: a report from the Children\u2019s Oncology Group","volume":"70","author":"Chisholm","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0010","series-title":"Haematolymphoid tumours","volume":"vol 11","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.hemonc.2018.03.001","article-title":"Myeloid sarcoma with megakaryoblastic differentiation presenting as a breast mass","volume":"11","author":"Obiorah","year":"2018","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0020","doi-asserted-by":"crossref","first-page":"13814","DOI":"10.1073\/pnas.0906556106","article-title":"Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage","volume":"106","author":"Kruse","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0025","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2010-11-320515","article-title":"Promotion and maintenance of leukemia by ERG","volume":"117","author":"Tsuzuki","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0030","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1158\/0008-5472.CAN-05-0147","article-title":"The proto-oncogene ERG in megakaryoblastic leukemias","volume":"65","author":"Rainis","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0035","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1158\/0008-5472.CAN-09-0075","article-title":"ERG is a megakaryocytic oncogene","volume":"69","author":"Salek-Ardakani","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2022.03.001","article-title":"Myeloid sarcoma and extramedullary hematopoiesis expand the spectrum of ERG-positive proliferations: an ancillary tool in the diagnosis","volume":"124","author":"Vargas","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/PAI.0000000000000958","article-title":"ERG immunoreactivity in blastic hematolymphoid neoplasms: diagnostic pitfall in the workup of undifferentiated malignant neoplasms","volume":"30","author":"Koo","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00000478-200109000-00007","article-title":"CD31 expression in intratumoral macrophages: a potential diagnostic pitfall","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152709_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI119129","article-title":"The biology of PECAM-1","volume":"99","author":"Newman","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0060","first-page":"817","article-title":"Myeloid sarcoma with RBM15::MRTFA (MKL1) mimicking vascular neoplasm","volume":"484","author":"G\u00fcndo\u011fdu","year":"2024","journal-title":"Virchows Arch"},{"issue":"3\u20134","key":"10.1016\/j.anndiagpath.2026.152709_bb0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/10428199509056827","article-title":"PECAM-1: its expression and function as a cell adhesion molecule on hemopoietic and endothelial cells","volume":"17","author":"Watt","year":"1995","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152709_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/jcp.50.6.490","article-title":"CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells","volume":"50","author":"Govender","year":"1997","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152709_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.anndiagpath.2013.08.003","article-title":"CD31 expression in plasmacytic\/plasmablastic lesions","volume":"17","author":"Plocharczyk","year":"2013","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152709_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamadermatol.2013.7141","article-title":"Expression of CD31\/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms","volume":"150","author":"Salva","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0085","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood-2006-06-031898","article-title":"The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis","volume":"109","author":"Tober","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41375-024-02453-x","article-title":"Endothelial heterogeneity in bone marrow: insights across development, adult life and leukemia","volume":"39","author":"Boueya","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0095","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00018-016-2134-0","article-title":"Specification and function of hemogenic endothelium during embryogenesis","volume":"73","author":"Gritz","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.2021012827","article-title":"The bone marrow niche from the inside out: how megakaryocytes are shaped by and shape hematopoiesis","volume":"139","author":"Stone","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2026.152709_bb0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ajcp\/98.2.214","article-title":"Acute megakaryoblastic leukemia in infants with t(1;22)(p13;q13) abnormality","volume":"98","author":"Chan","year":"1992","journal-title":"Am J Clin Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342600105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342600105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:31:51Z","timestamp":1788967911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109291342600105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":21,"alternative-id":["S109291342600105X"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152709","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ERG and CD31 expression in acute megakaryoblastic leukemia and myeloid sarcoma: A diagnostic pitfall","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152709"}}